(Total Views: 140)
Posted On: 10/13/2021 11:36:06 AM
Post# of 21199
$AVCO News : Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Co-develop Innovative In-Silico Technology, Enabling the Design and Synthesis of Novel Cell Membrane Receptor Targets for Cancer and Immune-Related Diseases
https://marketwirenews.com/news-releases/aval...03303.html
(0)
(0)Scroll down for more posts ▼
